Danaher unit IDT expands DNA synthesis capabilities to support high-diversity assays

Danaher unit Integrated DNA Technologies expanded DNA synthesis capabilities to cover higher-diversity designs, larger scale-up, and faster turnaround.

• The move targets precision-oncology workflows, extending IDT’s position in MRD and MCED research assays that require high-diversity oligonucleotides.
• IDT set up a pilot lab at its Innovation Nexus in Sunnyvale to speed development, optimization, and deployment of next-generation synthesis solutions.
• The expansion follows a more than threefold increase in synthesis capacity at IDT’s Coralville, Iowa site earlier this year.